Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › caspofungin

caspofungin

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of caspofungin

13 trials tracked of caspofungin: 10 in phase 3 or 4 and 4 with published results. The most-cited published study has 178 citations.

13Trials tracked
10Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 3 Phase 3 7 Phase 2 3
  1. Phase 3 Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections Completed · 178 cited
  2. Phase 3 Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Completed · 108 cited
  3. Phase 3 Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Completed · 39 cited
  4. Phase 3 Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis Completed · 16 cited
  5. Phase 4 Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins Completed
  6. Phase 4 Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) Completed
Show 7 more trials
  1. Phase 4 Effect of Weight and/or Obesity on Caspofungin Drug Concentrations Completed
  2. Phase 3 A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) Completed
  3. Phase 3 A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) Completed
  4. Phase 3 A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED) Completed
  5. Phase 2 A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074) Completed
  6. Phase 2 CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension Completed
  7. Phase 2 Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systematic review and meta-analysis shows antifungal resistance rates vary in diabetic foot ulcer patients
Diabetes & Endocrinology Meta-analysis
Systematic review and meta-analysis shows antifungal resistance rates vary in diabetic foot ulcer patients Antifungal resistance high in diabetic foot ulcers
This systematic review and meta-analysis evaluated antifungal resistance in patients with diabetic foot ulcers.
Many diabetic foot ulcer infections resist common antifungals, especially nystatin and itraconazole.
May 1, 2026
Pooled analysis review of rezafungin versus caspofungin for candidemia and invasive candidiasis
Drug Pipeline
Pooled analysis review of rezafungin versus caspofungin for candidemia and invasive candidiasis Weekly Drug Clears Blood Fungus Faster Than Daily Treatment
This review synthesizes a pooled analysis of two randomized trials evaluating rezafungin versus caspofungin in adults with candidemia or inv…
A new weekly medication clears blood infections just as well as daily shots, offering hope for shorter care.
Apr 19, 2026
Case report describes multidrug-resistant Candida tropicalis IPFD misdiagnosed as malignancy before caspofungin response
Rheumatology Sys. Review
Case report describes multidrug-resistant Candida tropicalis IPFD misdiagnosed as malignancy before caspofungin response A Lung Infection That Looked Exactly Like Cancer Returning
This case report and literature review details a single patient with invasive pulmonary fungal disease caused by multidrug-resistant Candida…
A lung infection that mimicked recurring cancer in a lymphoma survivor highlights how rare fungi can be misdiagnosed as malignancy.
Frontiers Apr 15, 2026